Table 2 Pre-existing conditions in selected populations.
Starting population (n = 1567) | MV\(^{\dag }\) (n = 715) | No MV\(^{\ddag }\) (n = 137) | Final population (n = 401) | Dead (n = 150) | Discharged (n = 163) | Censored (n = 88) | |
---|---|---|---|---|---|---|---|
None | 239 (15.3) | 107 (15.0) | 29 (21.2) | 63 (15.7) | 14 (9.3) | 33 (20.2) | 16 (18.2) |
Hypertension | 905 (57.8) | 429 (60) | 73 (53.3) | 236 (58.9) | 104 (69.3) | 81 (49.7) | 51 (58.0) |
Obesity | 477 (30.4) | 203 (28.4) | 32 (23.4) | 126 (31.4) | 46 (30.7) | 55 (33.7) | 25 (28.4) |
Type II DM, not on insulin | 260 (16.6) | 106 (14.8) | 19 (13.9) | 58 (14.5) | 24 (16.0) | 27 (16.6) | 7 (8.0) |
Type II DM, on insulin | 117 (7.5) | 51 (7.1) | 6 (4.4) | 25 (6.2) | 10 (6.7) | 5 (3.1) | 10 (11.4) |
Type I DM | 11 (0.7) | 2 (0.3) | 2 (1.5) | 1 (0.2) | 0 (0) | 1 (0.6) | 0 (0) |
COPD | 133 (8.5) | 53 (7.4) | 28 (8.9) | 25 (6.2) | 7 (4.7) | 13 (8.0) | 5 (5.7) |
COPD, moderate | 114 (7.3) | 48 (6.7) | 9 (6.6) | 23 (5.7) | 6 (4.0) | 12 (7.4) | 5 (5.7) |
COPD, severe | 19 (1.2) | 5 (0.7) | 3 (2.2) | 2 (0.5) | 1 (0.7) | 1 (0.6) | 0 (0) |
Asthma | 65 (4.1) | 26 (3.6) | 3 (2.2) | 14 (3.5) | 5 (3.3) | 7 (4.3) | 0 (0) |
Restrictive lung disease | 6 (0.4) | 3 (0.4) | 0 (0) | 2 (0.5) | 0 (0) | 2 (1.2) | 0 (0) |
Myocardial infarction | 131 (8.4) | 65 (9.1) | 13 (9.5) | 31 (7.7) | 16 (10.7) | 12 (7.4) | 3 (3.4) |
Arrhythmia | 106 (6.8) | 38 (5.3) | 10 (7.3) | 20 (5.0) | 11 (7.3) | 6 (3.7) | 3 (3.4) |
CHF (NYHA class 2 or 3) | 40 (2.6) | 13 (1.8) | 6 (4.4) | 4 (1.0) | 2 (1.3) | 1 (0.6) | 1 (1.1) |
Cancer, not metastatic | 54 (3.4) | 25 (3.5) | 2 (1.5) | 13 (3.2) | 6 (4.0) | 7 (4.3) | 0 (0) |
Hematological disorders | 18 (1.1) | 9 (1.3) | 0 (0) | 5 (1.2) | 2 (1.3) | 1 (0.6) | 2 (2.3) |
Autoimmune diseases | 31 (2.0) | 12 (1.7) | 5 (3.6) | 8 (2.0) | 4 (2.7) | 3 (1.8) | 1 (1.1) |
CKD, moderate or severe | 80 (5.1) | 33 (4.6) | 8 (5.8) | 15 (3.7) | 6 (4.0) | 8 (4.9) | 1 (1.1) |
CKD, end-stage | 7 (0.4) | 1 (0.1) | 2 (1.5) | 1 (0.2) | 1 (0.7) | 0 (0) | 0 (0) |
Cerebrovascular disease | 54 (3.4) | 26 (3.6) | 7 (5.1) | 13 (3.2) | 7 (4.7) | 4 (2.5) | 2 (2.3) |
Hemiplegia or paraplegia | 13 (0.8) | 8 (1.1) | 2 (1.5) | 5 (1.2) | 3 (2.0) | 1 (0.6) | 1 (1.1) |
Neuromuscular disease | 11 (0.7) | 4 (0.6) | 3 (2.2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |